Clinic
Velocity Urgent Care, LLC
Velocity Urgent Care, LLC was paid $21.00M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoVELOCITY URGENT CARE, LLC
WILLIAMSBURG, VA 23188
WILLIAMSBURG, VA 23188
33aNPI1205350584assigned 07/28/2017
33bProvider typeUrgent Care Clinic/Center
28Total paid$21.00M
24GClaims527,887
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Virginia
Rank by total paid#2 of 51
Median peer was paid$182K
This provider vs. median115×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 36,242 | $1.16M | |
| 2019 | 59,762 | $2.14M | |
| 2020 | 59,872 | $2.64M | |
| 2021 | 86,711 | $3.54M | |
| 2022 | 64,569 | $2.96M | |
| 2023 | 108,615 | $3.97M | |
| 2024incomplete | 112,116 | $4.59M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 103,439 | 92,304 | $7.48M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 17% | 35,450 | 33,016 | $3.51M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 15% | 48,467 | 45,214 | $3.17M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 47,916 | 43,231 | $2.54M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 10.0% | 80,346 | 72,767 | $2.10M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.1% | 65,335 | 34,237 | $871K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.5% | 43,446 | 40,233 | $522K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 1,538 | 1,425 | $151K |
| 87428 | <1% | 2,844 | 2,610 | $106K | |
| 87430 | <1% | 6,087 | 5,697 | $76K | |
| 99205 | Prolong outpt/office vis | <1% | 541 | 480 | $64K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,190 | 1,118 | $54K |
53 more codes
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 19,787 | $52K |
| 87400 | <1% | 11,201 | $52K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,524 | $40K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,791 | $38K |
| 81025 | <1% | 5,197 | $33K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 877 | $29K |
| 81003 | <1% | 13,593 | $23K | |
| 87807 | <1% | 1,392 | $17K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 338 | $12K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 176 | $9K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 705 | $8K |
| 73610 | <1% | 329 | $8K | |
| 73630 | <1% | 315 | $7K | |
| 87420 | <1% | 669 | $6K | |
| S9083 | Global fee urgent care centers | <1% | 218 | $5K |
| 93000 | <1% | 356 | $4K | |
| 99051 | <1% | 22,739 | $4K | |
| 73130 | <1% | 118 | $3K | |
| 73140 | <1% | 110 | $3K | |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 47 | $2K |
| 3074F | <1% | 635 | $1K | |
| 99000 | <1% | 1,892 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 895 | $908.28 |
| 3078F | <1% | 337 | $850.00 | |
| 73562 | <1% | 27 | $767.78 | |
| 69209 | <1% | 58 | $644.41 | |
| 73110 | <1% | 29 | $553.73 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 640 | $459.64 |
| 3079F | <1% | 232 | $450.00 | |
| 82962 | <1% | 192 | $415.94 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 68 | $361.26 |
| 86580 | <1% | 46 | $343.08 | |
| 73030 | <1% | 13 | $300.58 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 321 | $269.33 |
| 80047 | <1% | 29 | $255.40 | |
| 74018 | <1% | 13 | $252.37 | |
| 90688 | <1% | 16 | $209.94 | |
| 99386 | <1% | 116 | $202.30 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 116 | $171.62 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 15 | $152.00 |
| 3075F | <1% | 48 | $100.00 | |
| 3080F | <1% | 39 | $100.00 | |
| 86769 | <1% | 31 | $94.13 | |
| 3077F | <1% | 45 | $75.00 | |
| 85014 | <1% | 29 | $68.61 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 28 | $57.09 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 84 | $54.29 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 378 | $13.58 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 41 | $2.77 |
| A9150 | Non-prescription drugs | 0% | 118 | $0.00 |
| 1125F | 0% | 180 | $0.00 | |
| 1159F | 0% | 989 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 106 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, BARBARA (VP)
| Provider | Location | Paid |
|---|---|---|
| Vidor Isd | Vidor, TX | $1.75M |
| Dillon County School District Three | Latta, SC | $715K |
| Tidewater Medical Transport, INC | Portsmouth, VA | $168K |
| Mandala Group INC. | Belen, NM | $74K |
| Faith Medical Group, PLLC | Morristown, TN | $72K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.